Status:
RECRUITING
The Pathogenesis of Depression - Possible Autoimmune Mechanisms
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Depression
Autoimmune Diseases
Eligibility:
All Genders
18+ years
Brief Summary
It has long been claimed that depression, and other psychiatric illness, might be a manifestation of immune dysregulation involving the Central nervous system. Depression is associated with a signific...
Eligibility Criteria
Inclusion
- Patients must meet DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) criteria for a diagnosis of depression.
- Sufficient knowledge of the Hebrew language
- A stabled mental state. If hospitalized, patients are scheduled for discharge based on clinical assessment of psychiatric symptoms.
Exclusion
- Mental co-morbidity.
Key Trial Info
Start Date :
February 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05293899
Start Date
February 15 2022
End Date
April 15 2026
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haemek medical center
Afula, Israel, 1910500